Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia.
Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia.
Heart Lung Circ. 2019 Oct;28(10):1484-1489. doi: 10.1016/j.hlc.2019.03.014. Epub 2019 Apr 12.
A coronary chronic total occlusion (CTO) is a common finding during coronary angiography and is associated with increased mortality and poorer cardiovascular prognosis. Technological developments in percutaneous strategies for revascularisation have resulted in increased interest in this area. However, until recently, there has been a paucity of robust scientific randomised data comparing the efficacy of medical management with percutaneous strategies. Both observational data, and to a lesser extent, randomised data, suggest that CTO percutaneous coronary intervention (PCI) should be considered in symptomatic patients. However, in the absence of any randomised data, CTO PCI should not be performed for prognostic benefit. Ongoing trials are needed to confirm these findings as well as to identify the optimal timing and strategy of such interventions.
冠状动脉慢性完全闭塞(CTO)是冠状动脉造影中的常见发现,与死亡率增加和心血管预后不良相关。经皮血运重建策略的技术发展导致人们对此领域的兴趣增加。然而,直到最近,在比较药物治疗与经皮策略的疗效方面,仍然缺乏强有力的科学随机数据。观察性数据,以及在较小程度上的随机数据,表明在有症状的患者中应考虑 CTO 经皮冠状动脉介入治疗(PCI)。但是,由于缺乏任何随机数据,不应出于预后获益的目的而进行 CTO PCI。需要进行正在进行的试验来证实这些发现,并确定此类干预的最佳时机和策略。